Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations

BMC Public Health

Wolfgang Koenig³  Richard Peter¹  Thorsten Nikolaus²  Mahir Karakas³  Michael Denkinger²  Jochen Klenk¹  Dietrich Rothenbacher¹ 

[1] Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Helmholtzstr 22, D-89081, Germany;Agaplesion Bethesda Clinic Ulm, Ulm, Germany;Department of Internal Medicine II-Cardiology, University of Ulm Medical Centre, Ulm, Germany

关键词: Risk factors;    Estimating equations;    Population-based study;    Chronic kidney disease;    Elderly;   

Others  :  1163632
DOI  :  10.1186/1471-2458-12-343

 received in 2011-11-29, accepted in 2012-04-27,  发布年份 2012

【 摘 要 】

Background

Chronic kidney disease (CKD) represents a global public health problem. Few data exist in the elderly. The objective of the current study is to estimate the prevalence of CKD by means of various established and new equations and to identify the main determinants of CKD in elderly.

Methods

The ActiFE Ulm (Activity and Function in the Elderly in Ulm) study is a population-based cohort study in people of 65 years and older. Kidney function was assessed by means of estimated glomerular filtration rate (eGFR) based on two creatinine- (Cr-; MDRD, CKD-EPI) and one cystatin C - (CysC-) based method. The relationship between various potential risk factors and CKD was quantified using unconditional logistic regression.

Results

A total of 1471 subjects were in the final analysis (mean age 75.6 years, SD 6.56). Overall, prevalence of CKD (eGFR < 60 mL/min/1.73 m²) was 34.3% by MDRD, 33.0% by CKD-EPI, and 14.6% by the CysC-based eGFR. All eGFRs showed statistically significant correlations with C-reactive protein, uric acid, as well as with lipid values. In multivariable analysis age was clearly related to prevalence of CKD and the risks were highest with the CysC-based equation. Females had a higher risk for CKD stages 3–5 with MDRD (OR 1.63; 95% CI: 1.23–2.16) whereas the OR was 1.23 (95% CI 0.92–1.65) with the CKD-Epi and OR = 0.89 (95% CI 0.58–1.34) with the CysC-based equation after multivariable adjustment. Although the cystatin C based definition of CKD resulted in a lower prevalence compared to the creatinine based ones, other measures of renal damage such as albuminuria were more prevalent in those defined by CysC-eGFR.

Conclusions

Prevalence of CKD is very variable based on the used estimating equation. More work is needed to evaluate the various estimating equations especially in elderly before we are able to assess the practical consequences of the observed differences.

【 授权许可】

   
2012 Rothenbacher et al.; licensee BioMed Central Ltd; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Matsushita K, van der Velde M, Astor BC, Woodward M, Chronic Kidney Disease Prognosis Consortium, et al.: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
• [2]Zhang Q, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Publ Health 2008, 8:117. BioMed Central Full Text
• [3]Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, et al.: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011, 79:1331-1340.
• [4]Nitsch D, Mann AG, Bulpitt C, Roderick PJ, Fletcher A: Impairment of kidney function and reduced quality-of-life in older people: a cross-sectional study. Age Ageing 2011, 40:381-387.
• [5]Levey AS, de Jong PE, Coresh J, Nahas ME, Astor BC, et al.: The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011, 80:17-28.
• [6]Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al.: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:37-147.
• [7]Denkinger MD, Franke S, Rapp K, Weinmayr G, Duran-Tauleria E, et al.: Accelerometer-based physical activity in a large observational cohort-study protocol and design of the activity and function of the elderly in Ulm (ActiFE Ulm) study. BMC Geriatr 2010, 10:50. BioMed Central Full Text
• [8]Klenk J, Büchele G, Rapp K, Franke S, Peter R, et al.: Walking on sunshine: effect of weather conditions on physical activity in older people. J Epidemiol Comm Health 2011. Feb 15. [Epub ahead of print] PubMed PMID: 21325149
• [9]Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, et al.: Using standardized serum Creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
• [10]Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, et al.: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
• [11]Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, et al.: Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 2011, 58:682-684.
• [12]Delanaye P, Pieroni L, Abshoff C, Lutteri L, Chapeklle JP, et al.: Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clin Chim Acta 2008, 398:118-124.
• [13]Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, et al.: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67:2089-2100.
• [14]Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, et al.: Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009, 48:122-127.
• [15]Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, et al.: Epidemiology and prognostic significance of chronic kidney disease in the elderly–the Three-City prospective cohort study. Nephrol Dial Transplant 2011, 26:3286-3295.
• [16]Shastri S, Tighiouart H, Katz R, Rifkin DE, et al.: Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol 2011, 6:1410-1417.
• [17]Stevens LA, Li S, Wang C, Huang C, Becker BN, et al.: Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010, 55(3 Suppl 2):S23-S33.
• [18]Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapää P, et al.: Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med 2010, 267:612-620.
• [19]Roberts GW, Ibsen PM, Schiøler CT: Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009, 38:698-703.
• [20]Delanaye P, Cavalier E, Saint-Remy A, Lutteri L, Krzesinski JM: Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest 2009, 69:344-349.
• [21]Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, et al.: Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol 2011, 6:1963-1972.
• [22]van den Brand JA, van Boekel GA, Willems HL, Kiemeney LALM, der Heijer M, et al.: Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant 2011, 26:3176-3181.
• [23]Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO: Metabolic risk factors associated with serum creatinine in a non-diabetic population. Eur J Epidemiol 2007, 22:707-713.
• [24]Roderick PJ, Atkins RJ, Smeeth L, Nitsch DM, Hubbard RB, et al.: Detecting chronic kidney disease in older people; what are the implications? Age Ageing 2008, 37:179-186.
• [25]Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, et al.: Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009, 20:2214-2222.
• [26]Peralta CA, Shlipak MG, Judd S, Cushman M, McCellan W, et al.: Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011, 305:1545-1552.
• [27]Zhang QL, Brenner H, Koenig W, Rothenbacher D: Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. Atherosclerosis 2010, 211:342-347.
• [28]Roos JF, Doust J, Tett SE, Kirkpatrick CM, et al.: Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children – A meta-analysis. Clin Biochem 2007, 40:383-391.
• [29]Glassock RJ, Winearls C: Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008, 3:1563-1568.
• [30]Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008, 23:1117-1121.
• [31]Lamb EJ, O’Riordian SE, Delaney MP: Kidney function in older people: pathology, assessment and management. Clin Chim Acta 2003, 334:25-40.
• [32]Larsson A, Hansson LO, Flodin M, Katz R, Shlipak MG: Calibration of the Siemens cystatin C immunoassay has changed over time. Clin Chem 2011, 57:777-778.